As mentioned above, in our study, we found that the GSTM1 null variant, as well as the presence of at least one null GSTM1 or GSTT1 variants, determines a more than twofold higher risk for developing COPD. Here, GSTM1 is linked to chronic obstructive pulmonary disease.